2022 American Transplant Congress » Kidney Infectious Non-Polyoma & Non-Viral Hepatitis

Date: Sunday, June 5, 2022

Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

Session Type: Poster Abstract

Meeting: 2022 American Transplant Congress

7:00pm-8:00pm: APN-Driven COVID-19 Monitoring Model for Kidney Transplant Patients

J. Yoo, S. Patel, T. Clevy-Schneller, A. Desai, R. Sodhi, D. Jain, S. Akkina

7:00pm-8:00pm: Analysis of Antibiotic Resistance and Risk Level of Preservation Fluid Microorganisms in Kidney Transplant Recipients

J. Li¹, X. Su¹, J. Han², Y. Huang², W. Wu¹, M. Wei², S. Yuan², C. Wu¹, J. Li¹, L. Liu¹, C. Wang¹

7:00pm-8:00pm: Antibody Response to Sars- Cov -2 Mrna Vaccine in Kidney Transplant Recipients

R. Mohamed Abdul Rahman, M. Alkadi, E. Abuhelaiqa, M. Jarman, A. Nauman, O. Fituri, M. Asim, A. Hamad, H. Tohid, P. Coyle, L. Abu Raddad, H. Al-Malki

7:00pm-8:00pm: Application of Metagenomicnext-Generation Sequencing in the Diagnosis and Treatment of Recurrent Urinary Tract Infections in Kidney Transplant Recipients

W. Duan, X. Tian, X. Wu, G. Cao, T. Yan

7:00pm-8:00pm: Bacterial Infections After Kidney Transplant Before and After the COVID-19 Pandemic

A. Perez Gutierrez¹, B. Juengel¹, S. Krishnamoorthy², P. J. Bachul¹, P. Witkowski³, R. Barth³, J. Fung¹

7:00pm-8:00pm: Case-Control Study of Belatacept as Maintenance Immunosuppression in Kidney Transplant Recipients Living with HIV

M. Tucker, C. Foppiano Palacios, E. Cohen, S. Virmani, P. Trubin, L. A-Barakat, M. M. Azar, M. Malinis

7:00pm-8:00pm: Clinical Outcomes with IR-tac to LCP-tac Conversion in a Kidney Transplant Population

F. Bartlett¹, J. Newman¹, T. Sprague¹, S. Patel¹, N. Rao², E. Andrade², V. Rohan², M. Casey², D. Dubay¹, D. Taber¹

7:00pm-8:00pm: Comparison of Cephalexin and Ciprofloxacin Prophylaxis for Urinary Tract Infection in Kidney Transplant Recipients

N. A. Pauley, M. Fitzmaurice, A. Poparad-Stezar, B. Summers, A. Jantz

7:00pm-8:00pm: Decreased Mortality from Sars-CoV-2 Infection in Kidney Transplant Recipients Over the Course of the Pandemic

Y. Al Azzi, P. Loarte, C. Pynadath, L. Liriano, M. Ajaimy, S. Kapoor, H. Yaffe, M. Le, J. Graham, J. Rocca, S. Greenstein, M. Kinkhabwala, E. Akalin

7:00pm-8:00pm: Does a Second Transplant Increase the Risk for CMV Infection? An Evaluation of the Incidence of CMV Viremia in the Previously Transplanted Kidney Recipient

J. Byrns¹, G. Katz-Greenberg²

7:00pm-8:00pm: Early versus Delayed Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

A. Hutchins¹, M. Leick², M. Keck², J. S. McMullen²

7:00pm-8:00pm: Evaluation of Prophylactic Valganciclovir Dosing in Kidney Transplant Recipients at an Urban Transplant Institution

E. Foster¹, D. Pierce¹, T. Cairns¹, S. Borgetti², I. Tzvetanov³, E. Benedetti³, C. Muran¹

7:00pm-8:00pm: Evaluation of the Management of Cytomegalovirus in Kidney Transplant Recipients After Establishment of a Multidisciplinary Cytomegalovirus Workgroup

A. Boyle, A. Spenningsby, H. Rhodes, T. Anderson-Haag

7:00pm-8:00pm: Experience with Covid-19 Infection and Vaccination in Combined Kidney/HSCT Recipients

M. Gibson¹, D. Belshe¹, G. Gregory¹, S. Tanna¹, M. Ison¹, S. Ildstad², J. R. Leventhal¹

7:00pm-8:00pm: HLA Alleles Add to Risk Stratification for CMV Infection in Renal Transplant Recipients

R. Patil¹, R. Prashar², M. Ramesh², A. Patel²

7:00pm-8:00pm: Impaired Humoral Response to Second Dose of BNT162b2 Messenger RNA COVID-19 Vaccine in Kidney Transplant Recipients in Japan: Prospective Observational Study

H. Sasaki¹, K. Hasegawa¹, M. Miura², H. Harada¹, D. Takamoto¹, Y. Takada¹, S. Harada¹, H. Tanaka¹

7:00pm-8:00pm: Improved Mortality in COVID-19 Kidney Transplant Recipients Treated with Bamlanivimab

A. Hamiduzzaman, U. Reddy

7:00pm-8:00pm: Incidence of Opportunistic Infections in Elderly Kidney Transplant Recipients on Belatacept

K. Khalil, S. Jonchhe, J. Stern, R. Robalino, Z. A. Stewart, S. A. Mehta, N. Ali, H. Neumann

7:00pm-8:00pm: Incidence of Urinary Tract Infection or Asymptomatic Bacteriuria in Kidney Transplant Recipients with Sulfamethoxazole-Trimethoprim vs. Pentamidine for Pneumocystis Jiroveci Pneumonia Prophylaxis

L. Selznick, H. Sweiss, C. Long, S. Bhayana, R. Hall

7:00pm-8:00pm: Incidence of Viral Infections in Kidney Transplant Recipients Using Reduced Induction and Steroid Free Maintenance Immunosuppression

P. Dunton, L. Von Stein, H. Winters, A. Schenk, T. Pesavento, R. M. Smith, K. Schnelle

7:00pm-8:00pm: Prebiotic Supplementation In Kidney Transplant Recipients For Preventing Infections And Gastrointestinal Upset: A Randomized Controlled Feasibility Study

S. Chan¹, C. M. Hawley¹, E. M. Pascoe², C. Z. Cao², S. B. Campbell², K. L. Campbell³, R. S. Francis², R. Hale¹, N. M. Isbel⁴, M. Morrison⁵, D. W. Johnson²

7:00pm-8:00pm: Pseudomonas Related Pseudoaneurysm and Rupture of Transplant Renal Artery with Devastating Consequences – A Case Series

S. Umapathy¹, S. Nielsen¹, A. Curtis¹, A. Reyad¹, J. Guiteau¹, N. Umezurike¹, S. Patel¹, W. Miller², L. Ostrosky-Zeichner², M. Madhrira³, I. Memon³, B. Sankarapandian³, S. Allam³

7:00pm-8:00pm: Reasons for Kidney Transplant Patients to Have Outpatient Urine Cultures in the First Year Post-Transplant: An Analysis of the USRDS

V. Hemmige¹, E. Akalin², M. Kinkhabwala³

7:00pm-8:00pm: Seasonal Variation of Cytomegalovirus Infection in Kidney Transplant Recipients

M. Jorgenson, B. Astor, C. Saddler, J. Smith, F. Aziz, D. Mandelbrot, N. Garg

7:00pm-8:00pm: The Effect of Late-Onset Cytomegalovirus Infection on the Outcome of Renal Allograft in Patients with Delayed Graft Function

M. Rahimi Shahmirzadi¹, M. Silverman¹, L. Gunaratnam², A. Jevnikar², A. A. House², S. Hosseini-Moghaddam³

7:00pm-8:00pm: The Evolution of Mortality in Kidney Transplant Recipients at a Single Center in the Era of Covid

M. M. Eiting, K. Phillips, L. Smith

7:00pm-8:00pm: The Impact of COVID-19 on Renal Function of Kidney Transplant Recipients: A Three-Month Prospective Study

R. D. Foresto¹, H. Fagundes², V. Lafico², H. Tedesco Silva Junior², M. P. Cristelli¹, J. Pestana¹

7:00pm-8:00pm: Use of Targeted T-Cell Therapy (Posoleucel) for the Treatment of Epstein-Barr Virus Associated Leiomyosarcoma in an Adult Kidney Transplant Recipient: A Case Report

R. Saranu¹, S. Nikiforow², V. Jo³, H. So², P. Stowe², S. Tripathi¹, F. Cardarelli⁴, A. Chandraker¹

7:00pm-8:00pm: Valganciclovir for the Prevention of CMV After Treatment of Rejection with Anti-Lymphocyte Depleting Antibodies in Kidney Transplant Recipients

M. Mahoney, J. Nelson, E. Kincaide, R. Hall, H. Sweiss

« View all sessions from the 2022 American Transplant Congress